Artykuły w czasopismach na temat „Neurodegenerative disease modeling”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Neurodegenerative disease modeling”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Bolus, Harris, Kassi Crocker, Grace Boekhoff-Falk i Stanislava Chtarbanova. "Modeling Neurodegenerative Disorders in Drosophila melanogaster". International Journal of Molecular Sciences 21, nr 9 (26.04.2020): 3055. http://dx.doi.org/10.3390/ijms21093055.
Pełny tekst źródłaCaldwell, Kim A., Corey W. Willicott i Guy A. Caldwell. "Modeling neurodegeneration in Caenorhabditiselegans". Disease Models & Mechanisms 13, nr 10 (1.10.2020): dmm046110. http://dx.doi.org/10.1242/dmm.046110.
Pełny tekst źródłaLi, Jonathan, i Ernest Fraenkel. "Phenotyping Neurodegeneration in Human iPSCs". Annual Review of Biomedical Data Science 4, nr 1 (20.07.2021): 83–100. http://dx.doi.org/10.1146/annurev-biodatasci-092820-025214.
Pełny tekst źródłaLepesant, Jean-Antoine. "The promises of neurodegenerative disease modeling". Comptes Rendus Biologies 338, nr 8-9 (sierpień 2015): 584–92. http://dx.doi.org/10.1016/j.crvi.2015.06.018.
Pełny tekst źródłaLouit, Aurélie, Todd Galbraith i François Berthod. "In Vitro 3D Modeling of Neurodegenerative Diseases". Bioengineering 10, nr 1 (10.01.2023): 93. http://dx.doi.org/10.3390/bioengineering10010093.
Pełny tekst źródłaLeventoux, Nicolas, Satoru Morimoto, Kent Imaizumi, Yuta Sato, Shinichi Takahashi, Kyoko Mashima, Mitsuru Ishikawa i in. "Human Astrocytes Model Derived from Induced Pluripotent Stem Cells". Cells 9, nr 12 (13.12.2020): 2680. http://dx.doi.org/10.3390/cells9122680.
Pełny tekst źródłaLi, Bang, Da-Jian He, Xiao-Jiang Li i Xiang-Yu Guo. "Modeling neurodegenerative diseases using non-human primates: advances and challenges". Ageing and Neurodegenerative Diseases 2, nr 3 (2022): 12. http://dx.doi.org/10.20517/and.2022.14.
Pełny tekst źródłaTrudler, Dorit, Swagata Ghatak i Stuart A. Lipton. "Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases". International Journal of Molecular Sciences 22, nr 15 (30.07.2021): 8196. http://dx.doi.org/10.3390/ijms22158196.
Pełny tekst źródłaHaider, Mohamad, Anjali Chauhan, Sana Tariq, Dharam Pal Pathak, Nadeem Siddiqui, Soni Ali, Faheem Hyder Pottoo i Ruhi Ali. "Application of In silico Methods in the Design of Drugs for Neurodegenerative Diseases". Current Topics in Medicinal Chemistry 21, nr 11 (4.08.2021): 995–1011. http://dx.doi.org/10.2174/1568026621666210521164545.
Pełny tekst źródłaWan, Wenbin, Lan Cao, Bill Kalionis, Shijin Xia i Xiantao Tai. "Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases". Stem Cells International 2015 (2015): 1–11. http://dx.doi.org/10.1155/2015/382530.
Pełny tekst źródłaChang, Chia-Yu, Hsiao-Chien Ting, Ching-Ann Liu, Hong-Lin Su, Tzyy-Wen Chiou, Horng-Jyh Harn i Shinn-Zong Lin. "Induced Pluripotent Stem Cells". Cell Transplantation 27, nr 11 (12.06.2018): 1588–602. http://dx.doi.org/10.1177/0963689718775406.
Pełny tekst źródłaNair B J, Bipin, i Akshay Rajendran. "Computer aided drug design using virtual screening and molecular energy calculation of a specific neurodegenerative diseases". International Journal of Engineering & Technology 7, nr 1.9 (1.03.2018): 141. http://dx.doi.org/10.14419/ijet.v7i1.9.9751.
Pełny tekst źródłaHarris, Alexander R., Patrick McGivern i Lezanne Ooi. "Modeling Emergent Properties in the Brain Using Tissue Models to Investigate Neurodegenerative Disease". Neuroscientist 26, nr 3 (13.09.2019): 224–30. http://dx.doi.org/10.1177/1073858419870446.
Pełny tekst źródłaElsaey, Mohamed A., Kazuhiko Namikawa i Reinhard W. Köster. "Genetic Modeling of the Neurodegenerative Disease Spinocerebellar Ataxia Type 1 in Zebrafish". International Journal of Molecular Sciences 22, nr 14 (8.07.2021): 7351. http://dx.doi.org/10.3390/ijms22147351.
Pełny tekst źródłaCao, Lei, Lan Tan, Teng Jiang, Xi-Chen Zhu i Jin-Tai Yu. "Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases". Molecular Neurobiology 52, nr 1 (23.08.2014): 244–55. http://dx.doi.org/10.1007/s12035-014-8867-6.
Pełny tekst źródłaCárdenas Torres, Andrés Mauricio, Luis Carlos Ealo Otero, Juliana Uribe Perez i Beatriz Liliana Gomez Gomez. "Using Machine Learning Algorithms for Neurodegenerative Disease Gait Classification". Ingenierías USBMed 14, nr 2 (18.09.2023): 8–14. http://dx.doi.org/10.21500/20275846.6081.
Pełny tekst źródłaChan, Anthony. "NEURODEGENERATIVE DISEASES". Reproduction, Fertility and Development 24, nr 1 (2012): 288. http://dx.doi.org/10.1071/rdv24n1ab251.
Pełny tekst źródłaBera, Indrani. "Current Therapy and Computational Drug Designing Approaches for Neurodegenerative Diseases -with Focus on Alzheimer’s and Parkinson’s." Current Signal Transduction Therapy 14, nr 2 (10.10.2019): 122–28. http://dx.doi.org/10.2174/1574362413666180312125419.
Pełny tekst źródłaOkano, Hideyuki, i Satoru Morimoto. "iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders". Cell Stem Cell 29, nr 2 (luty 2022): 189–208. http://dx.doi.org/10.1016/j.stem.2022.01.007.
Pełny tekst źródłaSun, Ming, i Yuanjia Wang. "Nonlinear model with random inflection points for modeling neurodegenerative disease progression". Statistics in Medicine 37, nr 30 (6.09.2018): 4721–42. http://dx.doi.org/10.1002/sim.7951.
Pełny tekst źródłaKumar, Mandeep, Nhung Thi Phuong Nguyen, Marco Milanese i Giambattista Bonanno. "Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders". Biomolecules 12, nr 3 (23.02.2022): 344. http://dx.doi.org/10.3390/biom12030344.
Pełny tekst źródłaWu, Ying-Chieh, Tuuli-Maria Sonninen, Sanni Peltonen, Jari Koistinaho i Šárka Lehtonen. "Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells". International Journal of Molecular Sciences 22, nr 14 (19.07.2021): 7710. http://dx.doi.org/10.3390/ijms22147710.
Pełny tekst źródłaMiccoli, Beatrice, Dries Braeken i Yi-Chen Ethan Li. "Brain-on-a-chip Devices for Drug Screening and Disease Modeling Applications". Current Pharmaceutical Design 24, nr 45 (16.04.2019): 5419–36. http://dx.doi.org/10.2174/1381612825666190220161254.
Pełny tekst źródłaKhan, Engila, Ikramul Hasan i M. Emdadul Haque. "Parkinson’s Disease: Exploring Different Animal Model Systems". International Journal of Molecular Sciences 24, nr 10 (22.05.2023): 9088. http://dx.doi.org/10.3390/ijms24109088.
Pełny tekst źródłaNajib, Nor H. M., Yong H. Nies, Syarifah A. S. Abd Halim, Mohamad F. Yahaya, Srijit Das, Wei L. Lim i Seong L. Teoh. "Modeling Parkinson’s Disease in Zebrafish". CNS & Neurological Disorders - Drug Targets 19, nr 5 (13.11.2020): 386–99. http://dx.doi.org/10.2174/1871527319666200708124117.
Pełny tekst źródłaSoufi, W., M. Merad, F. BOUKLI Hacene i S. Ghalem. "Study of Monoamine Oxidase-B and Indole Derivatives Using Two Molecular Docking Programs: Molegro and MOE". International Journal of Scientific Research and Management 8, nr 09 (30.09.2020): 25–31. http://dx.doi.org/10.18535/ijsrm/v8i09.c01.
Pełny tekst źródłaLozanska, Bonka, Milena Georgieva, George Miloshev i Charilaos Xenodochidis. "Ageing and Neurodegeneration – The Role of Neurotransmitters’ Activity". International Journal Bioautomation 26, nr 4 (grudzień 2022): 325–38. http://dx.doi.org/10.7546/ijba.2022.26.4.000879.
Pełny tekst źródłaCsöbönyeiová, Mária, Štefan Polák i L’uboš Danišovič. "Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer’s disease". Reviews in the Neurosciences 27, nr 5 (1.07.2016): 457–64. http://dx.doi.org/10.1515/revneuro-2015-0054.
Pełny tekst źródłaJhala, Shivraj S., i Alan S. Hazell. "Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism". Neurochemistry International 58, nr 3 (luty 2011): 248–60. http://dx.doi.org/10.1016/j.neuint.2010.11.019.
Pełny tekst źródłaVera, E., i L. Studer. "When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease". Development 142, nr 18 (15.09.2015): 3085–89. http://dx.doi.org/10.1242/dev.120667.
Pełny tekst źródłaD'Souza, Gary X., Shannon E. Rose, Allison Knupp, Daniel A. Nicholson, Christopher Dirk Keene i Jessica E. Young. "The application of in vitro ‐derived human neurons in neurodegenerative disease modeling". Journal of Neuroscience Research 99, nr 1 (13.03.2020): 124–40. http://dx.doi.org/10.1002/jnr.24615.
Pełny tekst źródłaShastry, Surabhi, Junkai Hu, Mingyao Ying i Xiaobo Mao. "Cell Therapy for Parkinson’s Disease". Pharmaceutics 15, nr 12 (22.11.2023): 2656. http://dx.doi.org/10.3390/pharmaceutics15122656.
Pełny tekst źródłaDolan, Michael-John, Martine Therrien, Saša Jereb, Tushar Kamath, Vahid Gazestani, Trevor Atkeson, Samuel E. Marsh i in. "Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro". Nature Immunology 24, nr 8 (27.07.2023): 1382–90. http://dx.doi.org/10.1038/s41590-023-01558-2.
Pełny tekst źródłaHu, Xinchao, Chengyuan Mao, Liyuan Fan, Haiyang Luo, Zhengwei Hu, Shuo Zhang, Zhihua Yang i in. "Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells". Stem Cells International 2020 (12.03.2020): 1–15. http://dx.doi.org/10.1155/2020/1061470.
Pełny tekst źródłaSuzuki, Mari, Kazunori Sango i Yoshitaka Nagai. "Roles of α-Synuclein and Disease-Associated Factors in Drosophila Models of Parkinson’s Disease". International Journal of Molecular Sciences 23, nr 3 (28.01.2022): 1519. http://dx.doi.org/10.3390/ijms23031519.
Pełny tekst źródłaKulikova, O. I., T. N. Fedorova i V. S. Orlova. "MODELING OF PARKINSON’S DISEASE USING ENVIRONMENTAL NEUROTOXINS (REVIEW)". Toxicological Review, nr 2 (28.04.2019): 9–15. http://dx.doi.org/10.36946/0869-7922-2019-2-9-15.
Pełny tekst źródłaKumar, Sunil, Amritha Manoharan, Jayalakshmi J, Mohamed A. Abdelgawad, Wael A. Mahdi, Sultan Alshehri, Mohammed M. Ghoneim i in. "Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation". RSC Advances 13, nr 14 (2023): 9513–29. http://dx.doi.org/10.1039/d3ra00526g.
Pełny tekst źródłaNilsson, Lars-Göran. "Memory Processes, Aging, Cognitive Decline, and Neurodegenerative Diseases". European Psychologist 11, nr 4 (styczeń 2006): 304–11. http://dx.doi.org/10.1027/1016-9040.11.4.304.
Pełny tekst źródłaXie, Y. Z., i R. X. Zhang. "Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery". Neurological Sciences 36, nr 1 (30.10.2014): 21–27. http://dx.doi.org/10.1007/s10072-014-1989-9.
Pełny tekst źródłaMuñoz, Sonia Sanz, Martin Engel, Rachelle Balez, Dzung Do-Ha, Mauricio Castro Cabral-da-Silva, Damian Hernández, Tracey Berg i in. "A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling". Cells 9, nr 9 (2.09.2020): 2018. http://dx.doi.org/10.3390/cells9092018.
Pełny tekst źródłaLaBarbera, Kelsie Mozzoni, Colleen Limegrover, Courtney Rehak, Raymond Yurko, Nicholas John Izzo, Nicole Knezovich, Emily Watto, Lora Waybright i Susan M. Catalano. "Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery". Journal of Neuroscience Methods 358 (lipiec 2021): 109180. http://dx.doi.org/10.1016/j.jneumeth.2021.109180.
Pełny tekst źródłaShahid, Mohammad, Muhammad Shahzad Cheema, Alexander Klenner, Erfan Younesi i Martin Hofmann-Apitius. "SVM Based Descriptor Selection and Classification of Neurodegenerative Disease Drugs for Pharmacological Modeling". Molecular Informatics 32, nr 3 (27.02.2013): 241–49. http://dx.doi.org/10.1002/minf.201200116.
Pełny tekst źródłaYefroyev, David A., i Sha Jin. "Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases". Biomedicines 10, nr 2 (19.01.2022): 208. http://dx.doi.org/10.3390/biomedicines10020208.
Pełny tekst źródłaBauer, Susanne, Lars Dittrich, Lech Kaczmarczyk, Melvin Schleif, Rui Benfeitas i Walker S. Jackson. "Translatome profiling in fatal familial insomnia implicates TOR signaling in somatostatin neurons". Life Science Alliance 5, nr 11 (3.10.2022): e202201530. http://dx.doi.org/10.26508/lsa.202201530.
Pełny tekst źródłaZacharias, Helena U., Christoph Kaleta, François Cossais, Eva Schaeffer, Henry Berndt, Lena Best, Thomas Dost i in. "Microbiome and Metabolome Insights into the Role of the Gastrointestinal–Brain Axis in Parkinson’s and Alzheimer’s Disease: Unveiling Potential Therapeutic Targets". Metabolites 12, nr 12 (5.12.2022): 1222. http://dx.doi.org/10.3390/metabo12121222.
Pełny tekst źródłaSchreiner, Thomas Gabriel, Ioana Creangă-Murariu, Bogdan Ionel Tamba, Nicolae Lucanu i Bogdan Ovidiu Popescu. "In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease". Biomolecules 12, nr 8 (18.08.2022): 1136. http://dx.doi.org/10.3390/biom12081136.
Pełny tekst źródłaMishima, Takayasu, Shinsuke Fujioka, Jiro Fukae, Junichi Yuasa-Kawada i Yoshio Tsuboi. "Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells". International Journal of Molecular Sciences 19, nr 12 (4.12.2018): 3870. http://dx.doi.org/10.3390/ijms19123870.
Pełny tekst źródłaPashova-Dimova, Shina, Peter Petrov, Sena Karachanak-Yankova i Anastas Pashov. "Neurodegenerative diseases associated antibody repertoire signatures in mimotope arrays based on cyclic versus linear peptides". Pharmacia 70, nr 4 (30.11.2023): 1439–47. http://dx.doi.org/10.3897/pharmacia.70.e115179.
Pełny tekst źródłaHegde, Krupa N., i Ajay Srivastava. "Drosophila melanogaster as a Tool for Amyotrophic Lateral Sclerosis Research". Journal of Developmental Biology 10, nr 3 (30.08.2022): 36. http://dx.doi.org/10.3390/jdb10030036.
Pełny tekst źródłaSentyabreva, A. V., E. A. Melnikova, E. A. Miroshnichenko, I. S. Tsvetkov i A. M. Kosyreva. "Morphofunctional changes of microglia in adult and old Wistar rats". Medical Immunology (Russia) 25, nr 3 (1.06.2023): 527–32. http://dx.doi.org/10.15789/1563-0625-mco-2757.
Pełny tekst źródła